Evofem Biosciences, Inc. Deal History & Licensing Activity
Evofem Biosciences, Inc. is a life sciences. Over the past three years, Evofem Biosciences, Inc. has been involved in 2 licensing and acquisition transactions, with a primary focus on Small Molecules (1 deal).
Deals (12mo)
0
Active Trials
0
Top Modality
Small Molecules
Focus Area
Women's Health
Evofem Biosciences, Inc. Pipeline Focus
Therapeutic areas and modalities where Evofem Biosciences, Inc. is most active based on deal history and clinical trial data.
Therapeutic Areas
Modalities
Evofem Biosciences, Inc. Strategic Signals
Key indicators of Evofem Biosciences, Inc.'s licensing and acquisition strategy, including patent expirations, pipeline gaps, and strategic priorities.
Strategic Profile
Acquisition Appetite
See How Your Asset Matches Evofem Biosciences, Inc.'s Portfolio
Use our deal calculator to benchmark upfront payments, milestones, and royalties for Women's Health assets — powered by data from 3,500+ real biopharma transactions.
Related Intelligence
Women's Health Deal Benchmarks
Market sizing, deal terms, and competitive landscape for women's health
Small Molecules Benchmarks
Upfront, milestone, and royalty benchmarks for small molecules deals
Other Benchmarks
Upfront, milestone, and royalty benchmarks for other deals
Deal Pulse
Track the latest biopharma licensing and acquisition deals across all therapeutic areas
All Company Profiles
Browse 850+ biotech and pharma company profiles with deal history and pipeline data
2026 Deal Benchmarks Report
About Evofem Biosciences, Inc. Licensing & Deal Activity
Evofem Biosciences, Inc. is a life sciences company that has been actively engaged in licensing transactions across the biopharma landscape. With 2 deals over the past three years, Evofem Biosciences, Inc. ranks among the actively acquisitive companies tracked by Ambrosia Ventures.
Key therapeutic areas of focus for Evofem Biosciences, Inc. include Women's Health (2 deals and trials). In terms of modality, Evofem Biosciences, Inc. has shown particular interest in small molecules, other.
Ambrosia Ventures tracks deal terms, pipeline data, patent expirations, and competitive positioning for Evofem Biosciences, Inc. and 850+ other biopharma companies. Use our deal calculator to benchmark your asset against Evofem Biosciences, Inc.'s historical deal terms, or explore all company profiles to find the best partner match for your pipeline.